Brief: Abbott To Acquire Exact Sciences, A Leader In Large And Fast-Growing Cancer Screening And Precision Oncology Diagnostics Segments

Abbott Laboratories

20/11/2025 12:36

Abbott Laboratories ABT.N:

ABBOTT TO ACQUIRE EXACT SCIENCES, A LEADER IN LARGE AND FAST-GROWING CANCER SCREENING AND PRECISION ONCOLOGY DIAGNOSTICS SEGMENTS

ABBOTT - EXACT SCIENCES SHAREHOLDERS TO RECEIVE $105 PER SHARE

ABBOTT: PROPOSED DEAL FOR TOTAL EQUITY VALUE OF APPROXIMATELY $21 BILLION.

ABBOTT: ACQUISITION WILL BE IMMEDIATELY ACCRETIVE TO ABBOTT'S REVENUE GROWTH AND GROSS MARGIN

ABBOTT: PROPOSED DEAL FOR TOTAL EQUITY VALUE OF APPROXIMATELY $21 BILLION

ABBOTT - EXACT SCIENCES TO BECOME ABBOTT SUBSIDIARY

ABBOTT: PROPOSED DEAL FOR ESTIMATED ENTERPRISE VALUE OF $23 BILLION

ABBOTT - FINANCING CONTEMPLATES ABSORPTION OF EXACT SCIENCES' ESTIMATED $1.8 BILLION OF NET DEBT

Source text: ID:nPn1Kpy24a

Further company coverage: ABT.N